EODData

OTCBB, LYPHF: Luye Pharma Group Ltd

17 Nov 2025
LAST:

0.3903

CHANGE:
 0.12
OPEN:
0.3903
HIGH:
0.3903
ASK:
0.0000
VOLUME:
700
CHG(%):
45.63
PREV:
0.2680
LOW:
0.3903
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

PROFILE

Name:Luye Pharma Group Ltd
About:Luye Pharma Group Ltd., together with its subsidiaries, develops, produces, markets, and sells pharmaceutical products in the People's Republic of China, the United States, Europe, and internationally. The company offers Lipusu for ovarian cancer and carcinoma of ovary; CMNa, a chemical sensitizer for cancer radiotherapy; Boyounuo, an injection for the treatment of various types of cancers; and Xuezhikang, a lipid-regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; and Seroquel, Seroquel XR, Erzofri, Rivastigmine Multi-Day Transdermal Patch, and Rivastigmine. In addition, the company offers Rykindo, an injection for the treatment of schizophrenia; and Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation. Further, it offers Oukai; Meibirui; Jinyouping; and other products. The company distributes and sells pharmaceutical drugs; research and development of antibody drugs; and manufactures and sells biopharmaceutical products. Luye Pharma Group Ltd. was founded in 1994 and is headquartered in Yantai, the People's Republic of China.
Sector:Healthcare
Address:No. 15 Chuang Ye Road, Yantai, China, 264003
Website:https://www.luye.cn
FIGI:BBG00MYZFRL7

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:13.40 
Forward P/E:11.51 
Price to Sales:0.27 
Price to Book:0.51 
Revenue:6.168B 
EBITDA:1.956B 
Shares:3.995B 
Market Cap:1.559B 

TECHNICAL INDICATORS

MA5:0.3124.6%
Week High:0.390.0%
Week Low:0.390.0%